Search Results - "Bonavita, S"

Refine Results
  1. 1

    Digital therapeutics in neurology by Abbadessa, G., Brigo, F., Clerico, M., De Mercanti, S., Trojsi, F., Tedeschi, G., Bonavita, S., Lavorgna, L.

    Published in Journal of neurology (01-03-2022)
    “…Digital therapeutics (DTx) is a section of digital health defined by the DTx Alliance as “delivering evidence-based therapeutic interventions to patients that…”
    Get full text
    Journal Article
  2. 2

    Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis by Sacco, R., Santangelo, G., Stamenova, S., Bisecco, A., Bonavita, S., Lavorgna, L., Trojano, L., D'Ambrosio, A., Tedeschi, G., Gallo, A.

    Published in European journal of neurology (01-04-2016)
    “…Background and purpose Depression is the most common psychiatric disorder in multiple sclerosis (MS). Self‐report depression scales are frequently used as…”
    Get full text
    Journal Article
  3. 3

    Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory by Solaro, C, Trabucco, E, Signori, A, Martinelli, V, Radaelli, M, Centonze, D, Rossi, S, Grasso, M G, Clemenzi, A, Bonavita, S, D'Ambrosio, A, Patti, F, D'Amico, E, Cruccu, G, Truini, A

    Published in PloS one (15-09-2016)
    “…Depression occurs in about 50% of patients with multiple sclerosis. The aims of this study was to investigate the prevalence of depressive symptoms in a…”
    Get full text
    Journal Article
  4. 4

    Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria by Solaro, Claudio, Cella, M., Signori, Alessio, Martinelli, Vittorio, Radaelli, Marta, Centonze, D., Sica, F., Grasso, M. G., Clemenzi, A., Bonavita, S., Esposito, S., Patti, F., D’Amico, E., Cruccu, G., Truini, A.

    Published in Journal of neurology (01-04-2018)
    “…Background Pain is a common and heterogeneous complication of multiple sclerosis (MS). In this multicenter, cross sectional study, we aimed at investigating…”
    Get full text
    Journal Article
  5. 5

    Influence of light and flow on taxon composition and photosynthesis of marine phototrophic biofilm in photobioreactors by Guzzon, A., Di Pippo, F., Bonavita, S., Congestri, R.

    Published in Marine environmental research (01-07-2021)
    “…In this study, marine biofilms were cultured in a flow-lane, semi-continuous photobioreactor at different irradiances and flows to evaluate their combined…”
    Get full text
    Journal Article
  6. 6

    Whole-Brain Propagation Delays in Multiple Sclerosis, a Combined Tractography-Magnetoencephalography Study by Sorrentino, P, Petkoski, S, Sparaco, M, Troisi Lopez, E, Signoriello, E, Baselice, F, Bonavita, S, Pirozzi, M A, Quarantelli, M, Sorrentino, G, Jirsa, V

    Published in The Journal of neuroscience (23-11-2022)
    “…Two structurally connected brain regions are more likely to interact, with the lengths of the structural bundles, their widths, myelination, and the topology…”
    Get full text
    Journal Article
  7. 7

    Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies by Casertano, S., Signoriello, E., Rossi, F., Di Pietro, A., Tuccillo, F., Bonavita, S., Lus, G.

    Published in European journal of neurology (01-12-2020)
    “…Rituximab (RTX), a chimeric anti‐CD20 monoclonal antibody, has demonstrated good efficacy as treatment in patients with resistant chronic inflammatory…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine by Signoriello, E., Foschi, M., Lanzillo, R., Frau, J., Cocco, E., Borriello, G., Ianniello, A., Trotta, M., Landi, D., Maniscalco, G. T., Ruscica, F., Toscano, S., Patti, F., Zanghì, A., D’Amico, E., Fantozzi, R., Centonze, D., Lus, G., Bonavita, S.

    Published in Journal of neurology (01-07-2024)
    “…Introduction C ladribine is an oral immune reconstitution therapy for relapsing multiple sclerosis (RMS). Hormonal and immune changes are responsible for the…”
    Get full text
    Journal Article
  12. 12

    Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment? by Bonavita, S., Sacco, R., Esposito, S., d'Ambrosio, A., Della Corte, M., Corbo, D., Docimo, R., Gallo, A., Lavorgna, L., Cirillo, M., Bisecco, A., Esposito, F., Tedeschi, G.

    Published in European journal of neurology (01-01-2017)
    “…Background and purpose In multiple sclerosis (MS), depression is a common disorder whose pathophysiology is still debated. To gain insights into the…”
    Get full text
    Journal Article
  13. 13

    Anxiety in Multiple Sclerosis: psychometric properties of the State-Trait Anxiety Inventory by Santangelo, G., Sacco, R., Siciliano, M., Bisecco, A., Muzzo, G., Docimo, R., De Stefano, M., Bonavita, S., Lavorgna, L., Tedeschi, G., Trojano, L., Gallo, A.

    Published in Acta neurologica Scandinavica (01-12-2016)
    “…Objective The aims of the present study were to examine psychometric properties of the Spielberger State‐Trait Anxiety Inventory (STAI‐Y‐1 and STAI‐Y‐2,…”
    Get full text
    Journal Article
  14. 14

    Cognitive impairment and memory disorders in relapsing–remitting multiple sclerosis: the role of white matter, gray matter and hippocampus by Sacco, R., Bisecco, A., Corbo, D., Della Corte, M., d’Ambrosio, A., Docimo, R., Gallo, A., Esposito, F., Esposito, S., Cirillo, M., Lavorgna, L., Tedeschi, G., Bonavita, S.

    Published in Journal of neurology (01-07-2015)
    “…Cognitive disorders occur in up to 65 % of multiple sclerosis (MS) patients; they have been correlated with different MRI measures of brain tissue damage,…”
    Get full text
    Journal Article
  15. 15

    BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab by Signoriello, E., Bonavita, S., Di Pietro, A., Abbadessa, G., Rossi, F., Miele, G., Casertano, S., Lus, G.

    Published in Multiple sclerosis and related disorders (01-08-2020)
    “…•Effectiveness of ocrelizumab is confirmed in clinical practice.•Higher BMI could influence CD20 repopulation after the treatment with Ocrelizumab.•Lymphocytes…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis by Esposito, S., Sparaco, M., Maniscalco, G.T., Signoriello, E., Lanzillo, R., Russo, C., Carmisciano, L., Cepparulo, S., Lavorgna, L., Gallo, A., Trojsi, F., Brescia Morra, V., Lus, G., Tedeschi, G., Saccà, F., Signori, A., Bonavita, S.

    Published in Multiple sclerosis and related disorders (01-01-2021)
    “…•A survey study on lifestyle/dietary habits of a cohort with multiple sclerosis (MS).•A snapshot of mostly proactive MS adult women, incline to healthy…”
    Get full text
    Journal Article
  20. 20

    Assessment of mycotoxins co‐occurrence in Italian dried figs and in dried figs‐based products by Di Sanzo, R., Carabetta, S., Campone, L., Bonavita, S., Iaria, D., Fuda, S., Rastrelli, L., Russo, Mt

    Published in Journal of food safety (01-12-2018)
    “…The possible contamination by aflatoxins (AFs), ochratoxin A (OTA), fumonisin B1 (FB1), fusaric acid (FA), and beauvericin (BEA), was investigated in 55…”
    Get full text
    Journal Article